Return to Listing

1 result(s) for

PI Name Protocol # Title
Anna Bar STUDY00019384 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PHASE 3 EFFICACY AND SAFETY STUDY OF PATIDEGIB TOPICAL GEL, 2%, FOR THE REDUCTION OF DISEASE BURDEN OF PERSISTENTLY DEVELOPING BASAL CELL CARCINOMAS (BCCS) IN SUBJECTS WITH BASAL CELL NEVUS SYNDROME
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080